Food Allergen Testing: How Labs Detect and Quantify the Big 9 Allergens


GEMINI (2026)


Milk, eggs, fish, crustacean shellfish, tree nuts, peanuts, wheat, soybeans, and sesame now make up the nine major food allergens recognized under U.S. federal law, a list that grew by one when sesame's labeling requirement took effect on January 1, 2023. For laboratories, the practical challenge is not simply confirming that an allergen is present in a raw ingredient, but reliably detecting and quantifying it after a product has been baked, fermented, or otherwise processed, conditions under which some analytical methods lose accuracy. Allergen testing is one piece of the broader food safety testing landscape, and it draws on three complementary technologies, enzyme-linked immunosorbent assay (ELISA), polymerase chain reaction (PCR), and liquid chromatography-tandem mass spectrometry (LC-MS/MS), each suited to a different stage of the supply chain and a different degree of processing.

Key Takeaways
  • Sesame became the ninth major food allergen under the FASTER Act on January 1, 2023, joining milk, eggs, fish, crustacean shellfish, tree nuts, peanuts, wheat, and soybeans.
  • ELISA remains the workhorse rapid screening method, but it can fail entirely in heavily processed or hydrolyzed matrices.
  • LC-MS/MS has detected allergens at levels up to 1,000 milligrams per kilogram in baked products where ELISA testing returned a false negative.
  • The U.S. Food and Drug Administration (FDA) has not established or endorsed a legally binding allergen threshold; the only codified numeric limit is the 20 parts per million gluten-free labeling standard.
  • FDA held a public meeting in February 2026 on whether to move toward a mandatory, risk-based reference-dose framework for allergen thresholds.

Why Food Allergen Testing Methods Differ by Matrix

The same allergenic protein behaves differently depending on how a food has been processed. Baking, hydrolysis, and fermentation can denature or fragment proteins, which changes how well a given method can detect them. That variability is why food allergen testing programs typically use more than one method rather than standardizing on a single platform across every product category.

ELISA, PCR, and LC-MS/MS: Matching Allergen Testing Method to Matrix

  • ELISA (enzyme-linked immunosorbent assay): uses antibody-antigen binding to detect allergenic proteins and remains the fastest, most widely deployed screening method, though it is prone to cross-reactivity with matrix components and can miss allergens in heavily processed foods where the target protein has been altered.
  • PCR: detects the DNA that encodes an allergen rather than the protein itself, which makes it useful for confirming ingredient or species identity, such as which tree nut is present, even in some processed matrices where protein-based methods struggle. DNA can still degrade unpredictably depending on the matrix.
  • LC-MS/MS: directly detects specific allergenic peptides through mass spectrometry rather than relying on antibody binding, making it the most reliable option for finished, processed, or hydrolyzed foods.

A peer-reviewed case documented in Clinical and Translational Allergy illustrates why matrix matters: in a bakery product that caused allergic reactions in children, ELISA testing failed to detect milk, egg, and soy allergens present at levels as high as 1,000 milligrams per kilogram, while an LC-MS/MS method, the same instrument class used in mycotoxin testing, targeting seven allergens detected them both before and after baking. The study's authors concluded that ELISA and PCR are not always sensitive enough in processed materials to reliably protect allergic consumers, while LC-MS/MS held up under the same conditions.

Allergen Testing Regulatory Thresholds: Where a Hard Number Exists

Unlike pathogen testing, allergen regulation in the United States does not currently rest on enforceable ppm limits for the nine major allergens. The FDA has stated plainly that it has not established allergen thresholds, which is why voluntary allergen advisory statements such as "may contain" are used inconsistently across the industry, without a uniform federal rule governing when they apply.

The one significant exception is gluten. FDA's 2013 final rule under 21 CFR 101.91 requires that any food labeled "gluten-free" contain less than 20 parts per million of gluten, a level chosen because it was the lowest reliably detectable using validated analytical methods at the time. A 2020 companion rule extended compliance to fermented, hydrolyzed, and distilled foods, including yogurt, sauerkraut, cheese, beer, and hydrolyzed plant proteins, precisely because conventional ELISA testing cannot reliably quantify gluten once its proteins are broken into peptides during fermentation or hydrolysis. FDA specifically names two ELISA kits it relies on for enforcement in these matrices.

That gap between one codified threshold and none for the other eight major allergens is now under active review. In January 2023, a joint FAO/WHO Expert Consultation reached consensus on allergen reference doses using a benchmark-dose, probabilistic risk-assessment approach, work that underlies voluntary industry programs and is shaping how regulators think about future thresholds.

A 2026 Regulatory Turning Point for Food Allergen Testing

In February 2026, the FDA held a virtual public meeting and listening session on food allergen thresholds, drawing nearly 1,800 registrants to discuss whether the agency should move from the current unregulated advisory-statement system toward a mandatory, risk-based reference-dose framework. FDA has since published a summary of key themes from that meeting and opened a public docket for further comment, with discussion points including how a future reference-dose framework might compare with the existing 20 ppm gluten-free standard. No threshold has been adopted, but the follow-up docket signals that allergen testing programs built today should anticipate more prescriptive federal requirements ahead, not fewer.

What This Means for Food Allergen Testing Laboratories

Laboratories running food allergen testing programs should treat method selection as matrix-dependent rather than one-size-fits-all: ELISA for rapid raw-ingredient and surface screening, PCR where species or ingredient identity is the question, and LC-MS/MS wherever a product has been baked, fermented, or hydrolyzed and a false negative carries real consumer risk. With FDA actively reconsidering whether to formalize allergen reference doses, laboratories that already validate LC-MS/MS methods against specific matrices will be better positioned if quantitative thresholds become enforceable in the coming years.




Frequently Asked Questions

What are the Big 9 food allergens?
Milk, eggs, fish, crustacean shellfish, tree nuts, peanuts, wheat, soybeans, and sesame. Sesame became the ninth major allergen under the FASTER Act, effective January 1, 2023.

Why does ELISA sometimes fail to detect allergens in processed food?
Baking, fermentation, and hydrolysis can denature or fragment the proteins that ELISA's antibodies are designed to recognize, which can cause the method to return a false negative even when the allergen is present at meaningful levels.

Is there a legal limit for allergen cross-contact in the United States?
Not for the major allergens generally. The FDA has not established or endorsed enforceable threshold levels for allergen cross-contact; the one codified numeric limit is the 20 parts per million standard for gluten-free labeling.

When is LC-MS/MS preferred over ELISA or PCR for allergen testing?
LC-MS/MS is preferred for finished, processed, fermented, or hydrolyzed foods, where protein structure has changed enough that antibody-based or DNA-based methods may miss the allergen entirely.

Is the FDA planning to set official allergen thresholds?
The FDA has not adopted a threshold but held a public meeting in February 2026 to gather input on a possible risk-based reference-dose framework, suggesting the regulatory landscape may become more prescriptive.

How is gluten-free labeling different from other allergen labeling?
Gluten-free labeling carries a specific, codified 20 parts per million limit under FDA's 2013 final rule, unlike the other major allergens, which rely on disclosure rather than an enforceable quantitative threshold.

This article was created with the assistance of generative AI and has undergone editorial review before publishing. LabX's editorial policy can be found here.